These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32020551)

  • 1. Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients.
    Conci S; Ruzzenente A; Simbolo M; Bagante F; Rusev B; Isa G; Lawlor RT; Pedrazzani C; Iacono C; Guglielmi A; Scarpa A
    Updates Surg; 2020 Mar; 72(1):119-128. PubMed ID: 32020551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.
    Simbolo M; Vicentini C; Ruzzenente A; Brunelli M; Conci S; Fassan M; Mafficini A; Rusev B; Corbo V; Capelli P; Bria E; Pedron S; Turri G; Lawlor RT; Tortora G; Bassi C; Guglielmi A; Scarpa A
    Sci Rep; 2018 May; 8(1):7119. PubMed ID: 29740198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
    Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
    Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
    Kim H; Heo MH; Kim JY
    BMC Gastroenterol; 2020 Jan; 20(1):20. PubMed ID: 31992208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
    Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
    J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates?
    Sakata J; Nomura T; Aono T; Kitami C; Yokoyama N; Minagawa M; Takizawa K; Miura K; Hirose Y; Ichikawa H; Nagahashi M; Shimada Y; Kobayashi T; Wakai T
    HPB (Oxford); 2021 Sep; 23(9):1371-1382. PubMed ID: 33558069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal analysis of metachronous double biliary tract cancers.
    Omori Y; Aoki S; Ono Y; Kokumai T; Yoshimachi S; Sato H; Kusaka A; Iseki M; Douchi D; Miura T; Maeda S; Ishida M; Mizuma M; Nakagawa K; Mizukami Y; Furukawa T; Unno M
    J Pathol; 2024 May; 263(1):113-127. PubMed ID: 38482714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer.
    Vivaldi C; Fornaro L; Ugolini C; Niccoli C; Musettini G; Pecora I; Cacciato Insilla A; Salani F; Pasquini G; Catanese S; Lencioni M; Masi G; Campani D; Fontantini G; Falcone A; Vasile E
    Oncologist; 2020 Oct; 25(10):886-893. PubMed ID: 32353192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crossing borders: A systematic review with quantitative analysis of genetic mutations of carcinomas of the biliary tract.
    Roos E; Soer EC; Klompmaker S; Meijer LL; Besselink MG; Giovannetti E; Heger M; Kazemier G; Klümpen HJ; Takkenberg RB; Wilmink H; Würdinger T; Dijk F; van Gulik TM; Verheij J; van de Vijver MJ
    Crit Rev Oncol Hematol; 2019 Aug; 140():8-16. PubMed ID: 31158800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer.
    Geredeli C; Artac M; Yildirim S; Inal A; Dede I; Guler T; Boruban MC; Koral L; Karaagac M; Zamani AG; Altinok T; Aribas O; Bozcuk H; Demirkazik A
    Tumour Biol; 2015 Jun; 36(6):4279-85. PubMed ID: 25596702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival.
    Alessandrino F; Williams K; Nassar AH; Gujrathi R; Silverman SG; Sonpavde G; Shinagare AB
    Radiology; 2020 Jun; 295(3):572-580. PubMed ID: 32228295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative detections of TP53 gene mutations improve the diagnosis and prognostic prediction of biliary tract cancers using droplet digital PCR.
    Xiao X; Zhou J; Fang M; Ji J; Huang C; Du F; Ai W; Wang Y; Gao Z; Qiu Z; Gao C
    J Clin Lab Anal; 2022 Jan; 36(1):e24103. PubMed ID: 34813121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome sequencing of 22 genes using tissue from patients with biliary tract cancer.
    Høgdall D; Larsen OF; Linnemann D; Svenstrup Poulsen T; Høgdall EV
    APMIS; 2020 Jan; 128(1):3-9. PubMed ID: 31628675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of surgery for recurrent biliary tract cancer: a single-center experience and systematic review of literature.
    Miyazaki Y; Kokudo T; Amikura K; Kageyama Y; Takahashi A; Ohkohchi N; Sakamoto H
    Jpn J Clin Oncol; 2017 Mar; 47(3):206-212. PubMed ID: 27940488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary cancer: Utility of next-generation sequencing for clinical management.
    Javle M; Bekaii-Saab T; Jain A; Wang Y; Kelley RK; Wang K; Kang HC; Catenacci D; Ali S; Krishnan S; Ahn D; Bocobo AG; Zuo M; Kaseb A; Miller V; Stephens PJ; Meric-Bernstam F; Shroff R; Ross J
    Cancer; 2016 Dec; 122(24):3838-3847. PubMed ID: 27622582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice.
    Jain A; Kwong LN; Javle M
    Curr Treat Options Oncol; 2016 Nov; 17(11):58. PubMed ID: 27658789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis.
    Dodoo GN; De B; Lee SS; Abi Jaoude J; Vauthey JN; Tzeng CD; Tran Cao HS; Katlowitz KA; Mandel JJ; Beckham TH; Minsky BD; Smith GL; Holliday EB; Koong AC; Das P; Taniguchi CM; Javle M; Koay EJ; Ludmir EB
    Oncologist; 2023 Apr; 28(4):327-332. PubMed ID: 36715178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M; Peraud A; Leroch B; Kreth FW
    Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in biliary malignancy.
    Groot Koerkamp B; Fong Y
    J Surg Oncol; 2014 Oct; 110(5):585-91. PubMed ID: 25250887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic spectra of biliary tract cancer.
    Nakamura H; Arai Y; Totoki Y; Shirota T; Elzawahry A; Kato M; Hama N; Hosoda F; Urushidate T; Ohashi S; Hiraoka N; Ojima H; Shimada K; Okusaka T; Kosuge T; Miyagawa S; Shibata T
    Nat Genet; 2015 Sep; 47(9):1003-10. PubMed ID: 26258846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.